Life after Covid: For survivors, reinfection and health complications are becoming causes for concern

It is a bright Wednesday morning in the second week of September and about a dozen men and women wait in a Covid-appropriate queue to see a doctor at RML Hospital in New Delhi. All of them have one thing in common: they have beaten the Covid-19 virus. But that …

Read moreLife after Covid: For survivors, reinfection and health complications are becoming causes for concern

Post-Covid ailments may last for life: Dr Randeep Guleria, Pulmonology specialist and AIIMS Director

Pulmonology specialist and AIIMS Director Randeep Guleria is at the forefront of anti-Covid treatment in the country. He tells ET Magazine that reinfection is a reality now and a lot of research is being done to understand it. Edited excerpts of the interview: More people have started complaining about post-Covid …

Read morePost-Covid ailments may last for life: Dr Randeep Guleria, Pulmonology specialist and AIIMS Director

Chinese company says coronavirus vaccine ready by early 2021

Stringent regulations in the U.S., European Union, Japan and Australia have historically blocked the sale of Chinese vaccines. A Chinese pharmaceutical company said on Thursday the coronavirus vaccine it is developing should be ready by early 2021 for distribution worldwide, including the United States. Yin Weidong, the CEO of SinoVac, …

Read moreChinese company says coronavirus vaccine ready by early 2021

Stock markets face a big test as covid vaccine results likely from next month

Optimism that vaccines are on the way to end the coronavirus pandemic has been a major factor in this year’s U.S. stock resurgence. That will face a critical test in coming weeks, as investors await clinical data on whether they actually work. A UBS analysis found that about 40% of …

Read moreStock markets face a big test as covid vaccine results likely from next month

India needs to invest Rs 5K cr to give all Indians Covid vaccine: Zydus Cadila Chairman

As the world waits expectantly for COVID-19 vaccine, Zydus Cadila Chairman Pankaj R Patel said India would need to invest between Rs 3,000-5,000 crore to create additional facilities for making a huge number of vaccines required for the Indian population. He also said that the vaccine alone is not the …

Read moreIndia needs to invest Rs 5K cr to give all Indians Covid vaccine: Zydus Cadila Chairman